共 26 条
[1]
Grothy A., Risk assessment in stage II colon cancer: to treat or not to treat, Oncology (Williston Park), 24, SUPPL. 1, pp. 1-2, (2010)
[2]
O'Connell M., Maillard J.A., Kahn M.J., Et al., Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer, J Clin Oncol, 15, pp. 246-250, (1997)
[3]
O'Connell M., Laurie J.A., Kahn M.J., Et al., Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer, J Clin Oncol, 16, pp. 295-300, (1998)
[4]
Benson III A.B., Schrag D., Somerfield M.R., Et al., American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer, J Clin Oncol, 22, pp. 3408-3419, (2004)
[5]
Compton C.C., Fielding L.P., Burgart L.J., Et al., Prognostic factors in colorectal cancer. College of American pathologists consensus statement 1999, Arch Pathol Lab Med, 124, pp. 979-994, (2000)
[6]
Engstrom P.F., Benson III A.B., Saltz L., National comprehensive cancer network: colon cancer. Clinical practice guidelines in oncology, J Natl Compr Canc Netw, 1, pp. 40-53, (2003)
[7]
Obrocea F.L., Sajin M., Marinescu E.C., Stoica D., Colorectal cancer and the 7th revision of the TNM staging system: review of changes and suggestions for uniform pathologic reporting, Rom J Morphol Embryol, 52, pp. 537-544, (2011)
[8]
Pheby D.F., Levine D.F., Pitcher R.W., Shepherd N.A., Lymph node harvests directly influence the staging of colorectal cancer: evidence from a regional audit, J Clin Pathol, 57, pp. 43-47, (2004)
[9]
Ratto C., Sofo L., Ippoliti M., Et al., Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance, Dis Colon Rectum, 42, pp. 143-154, (1999)
[10]
Vather R., Sammour T., Kahokehr A., Connolly A.B., Hill A.G., Lymph node evaluation and long-term survival in stage II and stage III colon cancer: a national study, Ann Surg Oncol, 16, pp. 585-593, (2009)